Opvia Logo
Opvia Logo
Building a robust QMS with IMU Biosciences

Customers

Building a robust QMS with IMU Biosciences

quotation marks
Tali Kauffmann
Product Marketer at Opvia
1 minute read
IMU Biosciences logo
Company

IMU Biosciences

Size

20-30 employees

Industry
Biotechnology
Solution

IMU, based in London, UK, is an innovator in the field of precision immune medicine, dedicated to unlocking the potential of the immune system through deep, systems-level analysis.

With its proprietary platform, IMU is pioneering the use of AI and ML analytics to translate vast system level immune data into actionable insights and tools to drive the development of precision medicine across a range of health conditions and treatment responses, aiming to build a comprehensive Immune Atlas that covers the spectrum of health and disease, to advance precision medicine. This technology is the result of ten years of research from King’s College London and was initially applied during the COVID-19 pandemic.

IMU’s team spans a wide range of healthcare experts, immunologists, technologists, and their laboratories in Canary Wharf offer machines of the latest technology to enable their researchers to make their bold mission a reality.

The IMU team uses Opvia for its intricate needs, covering aspects from lab documentation and experimental workflows to training programmes. Opvia’s system facilitates the rigorous documentation and quality control required to pioneer advancements in immune system profiling and precision medicine.

Opvia partners with IMU Biosciences to support immune profiling innovation
Opvia partners with IMU Biosciences to support immune profiling innovation